Clinical Trial Detail

NCT ID NCT02278185
Title Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

prostate cancer

Therapies

Goserelin

Degarelix

Histrelin acetate

Triptorelin

Leuprolide

Enzalutamide

Age Groups: adult

No variant requirements are available.